Does ENZALUTAMIDE Cause Condition aggravated? 366 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 366 reports of Condition aggravated have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.7% of all adverse event reports for ENZALUTAMIDE.
366
Reports of Condition aggravated with ENZALUTAMIDE
0.7%
of all ENZALUTAMIDE reports
35
Deaths
107
Hospitalizations
How Dangerous Is Condition aggravated From ENZALUTAMIDE?
Of the 366 reports, 35 (9.6%) resulted in death, 107 (29.2%) required hospitalization, and 16 (4.4%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 366 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which ENZALUTAMIDE Alternatives Have Lower Condition aggravated Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE